BioConvergence pour la Santé
Domaine d’Intérêt Majeur (DIM) de la Région Île-de-France
Apply to the EIT Health SCI FI programme with BioConvS
Applications have been prolonged until June 30th 2023!
BioConvS at the Festival Double Science
Le DIM BioConvS est partenaire officiel du Festival Double Science, le festival de la médiation scie…
2023 PhD fellowships call
BioConvS’ first wave of PhD fellowships allocations is now closed. This call aims at funding p…
Small-medium equipment call 2023
The first equipment call of the DIM BioConvS is now closed. Each year we will open a different call.…
3rd Bioprocessing and Manufacturing of Gene and Cell Therapy Products Course: attend for free
Application process We managed to reserve 5 places of the 30 available in this course through a part…
Apply to Genopole’s Shaker program
Do you have an innovating project to develop in a startup? Do you need help in developing your proof…
Grands Lieux d’Innovation & SESAME Filière – webinar march 9
Medicen and the other innovation clusters of the Île-de-France Region are organizing an information …
SESAME Filière
Call for projects from the Ile-de-France Region for the structuring of strategic Ile-de-France secto…
Innovation competition: i-PhD
To meet the great challenge of doubling the number of Deeptech startups in France, the government in…
Congrès France Bioproduction: attend for free
Apply to attend for free to the France Bioproduction Congress
What is BioConvS?
BioConvergence for Health (BioConvS) is a Domain of Major Research and Innovation (DIM) funded by the Ile de France region. It aims to structure the communities of synthetic biology, biotherapy and bioproduction to guide the transition from scientific excellence to innovation, and to position Île-de-France region as an international reference in the domain. BioConvS, led by Université Paris Cité in partnership with Sorbonne and Paris-Saclay universities, Curie Institute (PSL), Micalis Institute (INRAe), Evry Genopole cluster, APHP and INSERM groups actors from the public and private sectors and benefits from 12.5M€ support from the Ile de France Region.
Principal axes
BioConvS gathers the Île-de-France scientific community working on the following axes:
- Life sciences engineering and bioproduction
- Development of therapeutics proofs-of-principles
- New, high throughput, standardisable analythic methods
- Digital or AI tools to improve data analysis or modelling in quality control and production methods
- Guarantee an inclusive, ethical, sustainable Bioconvergence
Distributed Biofoundry
BioConvS will support a network of distributed biofounderies (with the participation of Sorbonne University, INRAe, Institut Curie, Genopole and Université Paris Cité) to make technologies for life design and engineering accessible to Île-de-France Region public and private R&D. This will include the acquisition and pooling of high-tech equipment dedicated to the molecular engineering of living systems and bioproduction to create genetic circuits, synthetic cells and bioprocesses on demand.
CollectivE Digital Intelligence Platform (DICE)
BioConvS will develop an AI-supported framework of digital resources to design, document and share BioConvS researchers’ profiles, expertise and projects in a virtual collaborative research space. This platform, open to the general public, will strengthen the capacity for exchange between DIM’s partners and society.
English